- Home
- CYBR vs FMS Comparison
CYBR vs FMS Comparison
Compare CYBR & FMS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CYBR
- FMS
- Stock Information
- Founded
- CYBR 1999
- FMS 1996
- Country
- CYBR Israel
- FMS Germany
- Employees
- CYBR N/A
- FMS N/A
- Industry
- CYBR Computer Software: Prepackaged Software
- FMS Misc Health and Biotechnology Services
- Sector
- CYBR Technology
- FMS Health Care
- Exchange
- CYBR Nasdaq
- FMS Nasdaq
- Market Cap
- CYBR 19.7B
- FMS 15.9B
- IPO Year
- CYBR 2014
- FMS 1996
- Fundamental
- Price
- CYBR $374.13
- FMS $27.05
- Analyst Decision
- CYBR Strong Buy
- FMS Hold
- Analyst Count
- CYBR 32
- FMS 1
- Target Price
- CYBR $411.56
- FMS $30.00
- AVG Volume (30 Days)
- CYBR 724.7K
- FMS 338.6K
- Earning Date
- CYBR 08-07-2025
- FMS 07-29-2025
- Dividend Yield
- CYBR N/A
- FMS 2.11%
- EPS Growth
- CYBR N/A
- FMS 27.83
- EPS
- CYBR N/A
- FMS 2.28
- Revenue
- CYBR $1,096,793,000.00
- FMS $21,068,786,202.00
- Revenue This Year
- CYBR $34.80
- FMS $2.74
- Revenue Next Year
- CYBR $19.50
- FMS $3.60
- P/E Ratio
- CYBR N/A
- FMS $24.09
- Revenue Growth
- CYBR 35.12
- FMS 0.10
- 52 Week Low
- CYBR $230.00
- FMS $17.93
- 52 Week High
- CYBR $421.00
- FMS $30.46
- Technical
- Relative Strength Index (RSI)
- CYBR 41.99
- FMS 39.69
- Support Level
- CYBR $388.00
- FMS $26.16
- Resistance Level
- CYBR $408.24
- FMS $28.87
- Average True Range (ATR)
- CYBR 15.44
- FMS 0.31
- MACD
- CYBR -3.25
- FMS -0.12
- Stochastic Oscillator
- CYBR 5.84
- FMS 12.92
About CYBR CyberArk Software Ltd.
CyberArk is a cybersecurity vendor focused on the identity market. The company's core privileged access management offering is a market leader in that subsegment, with more than half of the Fortune 500 as CyberArk customers. The identity security vendor was founded in 1999 and has around 9,000 customers across various industries. While CyberArk historically sold its security solutions primarily via on-premises licenses, over the past few years it has transitioned to a subscription recurring-revenue model.
About FMS Fresenius Medical Care AG
Fresenius Medical Care is the largest dialysis company in the world, treating about 300,000 patients from nearly 3,700 clinics worldwide as of December 2024. In addition to providing dialysis services, the firm is a leading supplier of dialysis products, including machines, dialyzers, and concentrates. Fresenius accounts for about 35% of the global dialysis products market, creating the world's only fully integrated dialysis business. Services account for about three-fourths of sales, while the balance is generated from medical technology products that enable dialysis treatments.